These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 10209184)

  • 1. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.
    Morris HR; Janssen JC; Bandmann O; Daniel SE; Rossor MN; Lees AJ; Wood NW
    J Neurol Neurosurg Psychiatry; 1999 May; 66(5):665-7. PubMed ID: 10209184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection.
    Oliva R; Tolosa E; Ezquerra M; Molinuevo JL; Valldeoriola F; Burguera J; Calopa M; Villa M; Ballesta F
    Arch Neurol; 1998 Aug; 55(8):1122-4. PubMed ID: 9708963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tau gene A0 allele and progressive supranuclear palsy.
    Hoenicka J; Pérez M; Pérez-Tur J; Barabash A; Godoy M; Vidal L; Astarloa R; Avila J; Nygaard T; de Yébenes JG
    Neurology; 1999 Oct; 53(6):1219-25. PubMed ID: 10522876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tau A0 allele in Parkinson's disease.
    Golbe LI; Lazzarini AM; Spychala JR; Johnson WG; Stenroos ES; Mark MH; Sage JI
    Mov Disord; 2001 May; 16(3):442-7. PubMed ID: 11391737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders.
    Panegyres PK; Zafiris-Toufexis K
    Eur J Neurol; 2002 Sep; 9(5):485-9. PubMed ID: 12220379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the understanding of tau protein and movement disorders.
    Arvanitakis Z; Wszolek ZK
    Curr Opin Neurol; 2001 Aug; 14(4):491-7. PubMed ID: 11470966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy.
    Di Maria E; Tabaton M; Vigo T; Abbruzzese G; Bellone E; Donati C; Frasson E; Marchese R; Montagna P; Munoz DG; Pramstaller PP; Zanusso G; Ajmar F; Mandich P
    Ann Neurol; 2000 Mar; 47(3):374-7. PubMed ID: 10716259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant association between the tau gene A0/A0 genotype and Parkinson's disease.
    Pastor P; Ezquerra M; Muñoz E; Martí MJ; Blesa R; Tolosa E; Oliva R
    Ann Neurol; 2000 Feb; 47(2):242-5. PubMed ID: 10665497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive supranuclear palsy: earlier age of onset in patients with the tau protein A0/A0 genotype.
    Molinuevo JL; Valldeoriola F; Alegret M; Oliva R; Tolosa E
    J Neurol; 2000 Mar; 247(3):206-8. PubMed ID: 10787116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
    Kertesz A; Munoz D
    Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy.
    Delisle MB; Murrell JR; Richardson R; Trofatter JA; Rascol O; Soulages X; Mohr M; Calvas P; Ghetti B
    Acta Neuropathol; 1999 Jul; 98(1):62-77. PubMed ID: 10412802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease.
    de Silva R; Hardy J; Crook J; Khan N; Graham EA; Morris CM; Wood NW; Lees AJ
    Neurosci Lett; 2002 Sep; 330(2):201-3. PubMed ID: 12231446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4.
    Ingelson M; Fabre SF; Lilius L; Andersen C; Viitanen M; Almkvist O; Wahlund LO; Lannfelt L
    Neuroreport; 2001 Apr; 12(5):905-9. PubMed ID: 11303757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy.
    Conrad C; Amano N; Andreadis A; Xia Y; Namekataf K; Oyama F; Ikeda K; Wakabayashi K; Takahashi H; Thal LJ; Katzman R; Shackelford DA; Matsushita M; Masliah E; Sawa A
    Neurosci Lett; 1998 Jul; 250(2):135-7. PubMed ID: 9697937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene.
    Higgins JJ; Litvan I; Pho LT; Li W; Nee LE
    Neurology; 1998 Jan; 50(1):270-3. PubMed ID: 9443491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic aspects of progressive supranuclear palsy.
    Litvan I; Hutton M
    J Geriatr Psychiatry Neurol; 1998; 11(2):107-14. PubMed ID: 9877531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans.
    Ezquerra M; Pastor P; Valldeoriola F; Molinuevo JL; Blesa R; Tolosa E; Oliva R
    Neurosci Lett; 1999 Nov; 275(3):183-6. PubMed ID: 10580705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders.
    Webb A; Miller B; Bonasera S; Boxer A; Karydas A; Wilhelmsen KC
    Arch Neurol; 2008 Nov; 65(11):1473-8. PubMed ID: 19001166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
    Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
    J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies.
    Vacchi E; Lazzarini E; Pinton S; Chiaro G; Disanto G; Marchi F; Robert T; Staedler C; Galati S; Gobbi C; Barile L; Kaelin-Lang A; Melli G
    Brain; 2022 Aug; 145(8):2755-2768. PubMed ID: 35485527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.